reports
Axogen, Inc. to report 2025 first quarter financial results on May 8, ...
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025 ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2025 first quarter financial results on Thursday, May 8, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conference call by phone may do so by di...
Axogen Announces Appointment of Rick Ditto as Vice President, Global H...
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ALACHUA, Fla. and TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy. Mr. Ditto will report to Michael Dale, President, and Chief Executive Officer, and will lead the development of...
- Jonathan Moreland
PEB PEBBLEBROOK HOTEL TRUST
MTDR MATADOR RESOURCES COMPANY
JCOM J2 GLOBAL INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
HUN HUNTSMAN CORPORATION
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
ETSY ETSY INC.
ECPG ENCORE CAPITAL GROUP INC.
DAKT DAKTRONICS INC.
ASYS AMTECH SYSTEMS INC.
ARCC ARES CAPITAL CORPORATION
CMCO COLUMBUS MCKINNON CORPORATION
FMC FMC CORPORATION
MAC MACERICH COMPANY
WVE WAVE LIFE SCIENCES
PLBC PLUMAS BANCORP
FBK FB FINANCIAL CORPORATION
CWH CAMPING WORLD HOLDINGS INC. CLASS A
FLGT FULGENT GENETICS
PK PARK HOTELS & RESORTS INC.
FTDR FRONTDOOR INC.
AX AXOS FINANCIAL INC.
STRA STRATEGIC EDUCATION INC.
LBSRD LIBERTY STAR URANIUM & METALS
BCDA BIOCARDIA
ALEC ALECTOR
AMCR AMCOR PLC
RVLV REVOLVE GROUP
GO GROCERY OUTLET HOLDING
NOG NORTHERN OIL AND GAS
UAN CVR PARTNERS LP
PFX PHENIXFIN CORP
CLVT CLARIVATE PLC
KIND NEXTDOOR HLDGS INC
BHVN BIOHAVEN LTD
BHRB BURKE & HERBERT BANK & TR/VA
MAIA MAIA BIOTECHNOLOGY INC
AMWL AMERICAN WELL CORP
Axogen, Inc. To Host Analyst & Investor Day on March 4th
Axogen, Inc. To Host Analyst & Investor Day on March 4th ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, will hold its Analyst & Investor Day on March 4, 2025, between 9am-12pm Eastern. Featured speakers will include Chief Executive Officer - Michael Dale, Chief Financial Officer - Nir Naor, and other senior members of the leadership team. During the event, the Axogen team will offer an overview of the business, strategic initiatives and g...
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Resul...
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full-year ended December 31, 2024. Fourth Quarter 2024 Financial Results and Business Highlights Fourth quarter revenue was $49.4 million, a 15.1% increase compared to the fourth quarter of 2023.Gross margin was 76.1% for the fourth ...
Axogen, Inc. to report 2024 fourth quarter and full year financial res...
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2024 fourth quarter and full year financial results on Tuesday, February 25, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating i...
Axogen Announces Appointment of Jesse Bishop as Vice President of Regu...
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jesse Bishop as Vice President of Regulatory Affairs. Mr. Bishop will report to Michael Dale, President, and Chief Executive Officer, and will lead the development and execution of domestic and international regulator...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols bymarket-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
WHR WHIRLPOOL CORPORATION
SLAB SILICON LABORATORIES INC.
LAKE LAKELAND INDUSTRIES INC.
GTE GRAN TIERRA ENERGY
DXPE DXP ENTERPRISES INC.
COG CABOT OIL & GAS CORPORATION
AXGN AXOGEN INC.
ALLT ALLOT LTD
MEG. MEG ENERGY CORP.
PARR PAR PACIFIC HOLDINGS INC
VFC V.F. CORPORATION
CDZI CADIZ INC.
IRTC IRHYTHM TECHNOLOGIES INC.
DK DELEK US HOLDINGS INC
SWTX SPRINGWORKS THERAPEUTICS
PGNY PROGYNY
CRMD CORMEDIX INC.
LPI LAREDO PETROLEUM INC.
FNMA FEDERAL NATIONAL MORTGAGE ASSOCIATION
OVV OVINTIV INC
PTLO PORTILLOS INC
CIVI CIVITAS RESOURCES INC
ARHS ARHAUS INC
OPFI OPPFI INC
FTAI FORTRESS TRANSN & INFRAS INVS LLC
SN SHARKNINJA INC
ARPL ARLA PLAST AB
Axogen Announces New VP of Operations and Inducement Grant Under Nasda...
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Craig Swandal, experienced medical device manufacturing executive, joins leadership team ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Craig Swandal as Vice President of Operations. Mr. Swandal will report to Michael Dale, President, and Chief Executive Officer, and will be responsible for manufacturing, sup...
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Fu...
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024 ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2024 key financials. Preliminary Fourth Quarter and Year-End Key Business Highlights Fourth quarter revenue is expected to be approximately $49.4 million, which represents a 15.1% increase over the fourth quarter of 2023 driven by s...
Assured Guaranty Ltd: 1 director
A director at Assured Guaranty Ltd sold 34,000 shares at 88.330USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
- Jonathan Moreland
NMFC NEW MOUNTAIN FINANCE CORPORATION
AUP AURINIA PHARMACEUTICALS INC.
SCVL SHOE CARNIVAL INC.
TREE LENDINGTREE INC.
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
QRTEA QURATE RETAIL INC. CLASS A
ORGO ORGANOGENESIS HOLDINGS (A)
ATEX ANTERIX
ETNB 89BIO
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
ONEW ONEWATER MARINE
RVMD REVOLUTION MEDICINES
BIGZ BLACKROCK INNOVATION AND GROWTH TST
GRNT GRANITE RIDGE RESOURCES INC
SRBK SR BANCORP INC
MRAI MARPAI
EVM INC.
EATON VANCE INSD CALIF MUN BD FD
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides ...
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third quarter ended September 30, 2024. Third Quarter Financial Results Third quarter revenue was $48.6 million, a 17.9% increase compared to the third quarter of 2023.In the third quarter of 2024, gross margin decreased to 74.9%, down from 76.8% i...
Axogen, Inc. to report third quarter 2024 financial results and host c...
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 ALACHUA, Fla. and TAMPA, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report third quarter 2024 financial results on Thursday, November 7, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the ...
Axogen Completes Submission of Biologics License Application to U.S. F...
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft® ALACHUA, Fla. and TAMPA, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®. “I am proud of the significant progress our team has made towards the regulatory transition o...
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing R...
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4) ALACHUA, Fla. and TAMPA, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced today that it has granted an equity inducement award on September 3, 2024, to a new non-executive employee under the terms of the Axogen Inc.’s Inducement Equity Incentive Plan. The award was approved by the Compensation Committee of Axogen’s Board of Directors in accordance with NASDAQ Listing Rule...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
WLDN WILLDAN GROUP
VIRC VIRCO MANUFACTURING CORP.
TBBK THE BANCORP
PSIX POWER SOLUTIONS INTERNATIONAL INC.
NWPX NORTHWEST PIPE CO.
KTOS KRATOS DEFENSE & SECURITY SOLUTIONS INC.
BFIN BANKFINANCIAL
AXGN AXOGEN INC.
ASPN ASPEN AEROGELS
MG/CN MAGNA INTERNATIONAL INC.
HRTG HERITAGE INSURANCE HOLDINGS INC.
AUP AURINIA PHARMACEUTICALS INC.
GLOB GLOBANT SA
NGS NATURAL GAS SERVICES GROUP INC.
SGMS SCIENTIFIC GAMES CORPORATION
HRB H&R BLOCK INC.
MHH MASTECH DIGITAL
KINS KINGSTONE COS. INC.
FEIM FREQUENCY ELECTRONICS INC.
SIGA SIGA TECHNOLOGIES INC.
SNFCA SECURITY NATIONAL FINANCIAL CORP. CL A
PSNL PERSONALIS
VHI VALHI INC.
KLXE KLX ENERGY SERVICES
MSGE MADISON SQUARE GARDEN ENTERTAINMENT
CLBT CELLEBRITE DI LTD
CINT CI&T INC
RKLB ROCKET LAB USA INC
PGRU PROPERTYGURU GROUP LTD
COHR COHERENT CORP
REAX ADL VENTURES INC
FTAI FORTRESS TRANSN & INFRAS INVS LLC
FIHL FIDELIS INSURANCE HOLDINGS LIMITED
LTH LIFE TIME GROUP HLDGS INC
ANG ANGLOGOLD ASHANTI LIMITED
HG HAMILTON INSURANCE GROUP LTD.
AKA AKA BRANDS HOLDING CORP
UBXG U BX TECHNOLOGY LTD
TEM TEMPUS AI INC
BVS BAYVIEW CAPITAL TRUST I PFD 9.76%
Axogen, Inc. Announces New Leadership Appointments
Axogen, Inc. Announces New Leadership Appointments The Board of Directors appoints Michael Dale as new CEO and Director, effective August 9, 2024Dale replaces Karen Zaderej, who will remain in an advisory role for nine monthsCurrent Member of the Board, Paul Thomas, will be the new Chairman of the Board, effective August 9, 2024 ALACHUA, Fla. and TAMPA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Michael Dale is appointed as chief execut...
Axogen, Inc. Reports Second Quarter 2024 Financial Results
Axogen, Inc. Reports Second Quarter 2024 Financial Results ALACHUA, Fla. and TAMPA, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the second quarter ended June 30, 2024. Second Quarter Financial Results Second quarter revenue was $47.9 million, a 25.6% increase compared to the second quarter of 2023.In the second quarter of 2024, our gross margin decreased t...
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host ...
Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conferen...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.